Publication | Closed Access
LO8 : Daclatasvir, sofosbuvir, and ribavirin combination for HCV patients with advanced cirrhosis or posttransplant recurrence: Phase 3 ALLY-1 study
94
Citations
0
References
2015
Year
Ally-1 StudyHcv PatientsHepatologyViral HepatitisAntiviral TherapyHepatitisVirologyLiver DiseaseAdvanced CirrhosisAntiviral DrugLiver TransplantationMedicine
No additional data available for this publication yet. Check back later!